Phase 1 study to evaluate the safety and tolerability of MEDI4736 (durvalumab, durva) plus tremelimumab (treme) in patients with advanced solid tumorsMargaret K. Callahan,Kunle Odunsi,Mario Sznol,John Nemunaitis,Patrick A. Ott,Patrick Dillon,Reva Schneider,Andrew Park,Paul Schwarzenberger,Toni Ricciardi,Mary Macri,Aileen Ryan,Ralph Venhaus,Jedd D. WolchokCANCER IMMUNOLOGY RESEARCH（2019）引用 1|浏览21暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
